sodium formylhippurate trifluoroacetylisobutyl dipeptide-42 amide hamilelikte güvenli mi?

Related ingredients

Frequently asked questions

sodium formylhippurate trifluoroacetylisobutyl dipeptide-42 amide hamilelikte güvenli mi?

No authoritative reproductive hazard information was found (no harmonised CLP entry, no SCCS or CIR safety assessment, no peer‑reviewed reproductive/toxicology studies). Searches of ECHA C&L, PubChem, CosIng, CIR, PubMed and EWG returned no harmful classifications or data indicating reproductive risk, so by default scoring and CIR/SCCS priority rules this is scored as no evidence of reproductive hazard.

sodium formylhippurate trifluoroacetylisobutyl dipeptide-42 amide emzirirken güvenli mi?

No data indicating toxicity to lactating people or transfer to breast milk was identified in authoritative sources (no SCCS/CIR opinions, no peer‑reviewed studies). In absence of evidence of systemic absorption or mammary transfer, default hazard/mechanism/exposure scores are 0.

sodium formylhippurate trifluoroacetylisobutyl dipeptide-42 amide bebek cildi için güvenli mi?

No infant- or dermal‑absorption specific data were identified in SCCS/CIR/ECHA/PubMed/EWG/CosIng. The ingredient appears to be a synthetic peptide/derivative (large, polar molecule) and there are no flags for dermal systemic toxicity; therefore hazard/mechanism default to 0. No reliable data indicate increased absorption in infants, so exposure remains 0 (note: if infant-specific absorption data appeared showing measurable uptake, exposure should be reassessed).

VeriMom sodium formylhippurate trifluoroacetylisobutyl dipeptide-42 amide nasıl puanlıyor?

VeriMom sodium formylhippurate trifluoroacetylisobutyl dipeptide-42 amide'yi EU CosIng, ECHA sınıflandırmaları ve PubMed çalışmalarına göre 100/100 (bilinen risk yok) olarak puanlar.

Hamilelikte sodium formylhippurate trifluoroacetylisobutyl dipeptide-42 amide yerine neler kullanılabilir?

Benzer işlevli ve bilinen riski olmayan alternatifleri içeren listemize bakın.